Align Technology, a global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and restorative dentistry, has appointed Emory Wright as Executive Vice President of the Direct Fabrication Manufacturing Platform, effective immediately.
Emory Wright will transition his current responsibilities for global operations, including treatment planning, and focus on scaling Align’s next-generation direct fabrication manufacturing platform, working in close collaboration with Srini Kaza, who was promoted to Executive Vice President of Research and Development.
“Emory has had an enormous impact on Align and the orthodontic industry as a whole and I am thrilled he will continue to provide his extensive knowledge and experience to help us accelerate our plans and further extend our leadership in 3D printing. Until his retirement in 2026, Emory will take on a new role, and in addition to helping with the transition of his existing duties, he will lead the development of our direct 3D printing capabilities and focus on building a world-class direct fabrication operation that can scale to support the global demand for our next generation products and services – including the Invisalign Palatal Expander and future orthodontic and dental appliances,” said Joe Hogan, President and CEO of Align Technology.
“Srini just crossed his 25th anniversary with Align and he is one of the most revered innovators of clear aligner therapy in the world – and his contributions to the most advanced clear aligner system in the world, the Invisalign system, are unprecedented. With our recent acquisition of Cubicure, Srini and his team are now pioneering the next generation of 3D printing technologies that will radically change clear aligner therapy in the future. I am pleased to have Srini continue to lead our next phase of innovation working closely with Emory in his new role, and I want to congratulate Srini on his promotion to executive vice president, research & development,” said Hogan.